Control Bionics Ltd
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electroni… Read more
Market Cap & Net Worth: Control Bionics Ltd (CBL)
Control Bionics Ltd (AU:CBL) has a market capitalization of $14.79 Million (AU$23.89 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31281 globally and #961 in its home market, demonstrating a 3.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Control Bionics Ltd's stock price AU$0.06 by its total outstanding shares 411961889 (411.96 Million).
Control Bionics Ltd Market Cap History: 2020 to 2026
Control Bionics Ltd's market capitalization history from 2020 to 2026. Data shows change from $216.26 Million to $14.79 Million (-42.39% CAGR).
Control Bionics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Control Bionics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.49x
Control Bionics Ltd's market cap is 2.49 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $216.26 Million | $4.09 Million | -$3.55 Million | 52.89x | N/A |
| 2021 | $97.77 Million | $4.50 Million | -$6.11 Million | 21.72x | N/A |
| 2022 | $37.96 Million | $5.64 Million | -$5.63 Million | 6.73x | N/A |
| 2023 | $11.73 Million | $5.35 Million | -$5.91 Million | 2.19x | N/A |
| 2024 | $15.30 Million | $6.14 Million | -$6.11 Million | 2.49x | N/A |
Competitor Companies of CBL by Market Capitalization
Companies near Control Bionics Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Control Bionics Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Control Bionics Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Control Bionics Ltd's market cap moved from $216.26 Million to $ 14.79 Million, with a yearly change of -42.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$14.79 Million | -4.92% |
| 2025 | AU$15.56 Million | +1.67% |
| 2024 | AU$15.30 Million | +30.43% |
| 2023 | AU$11.73 Million | -69.09% |
| 2022 | AU$37.96 Million | -61.18% |
| 2021 | AU$97.77 Million | -54.79% |
| 2020 | AU$216.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Control Bionics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.79 Million USD |
| MoneyControl | $14.79 Million USD |
| MarketWatch | $14.79 Million USD |
| marketcap.company | $14.79 Million USD |
| Reuters | $14.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.